Changes in Beneficial Ownership · 4
Guardant Health, Inc.
GHNASDAQEQUITYCurrent
Changes in Beneficial Ownership
Structured filing — 4
wk-form4_1791925851.xml
Filing details
- Report period
- 2026-10-12
- Issuer
- Guardant Health, Inc.
- Issuer CIK
- 0001576280
- Trading symbol
- GH
Reporting owner 1
- Name
- Azar Alex M II
- Reporting owner CIK
- 0001402256
- Relationship
- Director
- Address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
Non-derivative transactions
| Security | Transaction date | Code | Amount | A / D | Price (USD) | Owned after | Ownership |
|---|---|---|---|---|---|---|---|
| Common Stock | 2026-10-12 | M · Form 4 | 137 | A | 0 | 962 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- A
- Acquired
- D
- Direct
Derivative transactions
| Security | Conversion / exercise price (USD) | Transaction date | Code | Amount | A / D | Price (USD) | Exercisable | Expires | Underlying security | Underlying shares | Owned after | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock Units | 0 | 2026-10-12 | M · Form 4 | 137 | D | 0 | [F1] | [F2] | Common Stock | 137 | 4,816 | D |
Table key
- M · Form 4
- Exempt derivative exercise or conversion under Rule 16b-3
- D
- Direct
Footnotes
Signature 1
- Signed
- /s/ John G. Saia, as attorney-in-fact for Alex M. Azar II
- Date
- 2026-10-13
Company context
Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer.